Security key
02043Q107
ALNYLAM PHARMACEUTICALS, INC. - Common Stock (ALNY)
CUSIP: 02043Q107
Q2 2015 13F Holders as of 30 Jun 2015
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 133,131,695
- Total 13F shares
- 65,565,499
- Share change
- +1,096,378
- Total reported value
- $7,859,319,459
- Put/Call ratio
- 121%
- Price per share
- $119.87
- Number of holders
- 274
- Value change
- +$143,389,344
- Number of buys
- 172
- Number of sells
- 102
Report period
Q2 2015
Institutions
274
Top holders
10
ALNY full security history
Newer quarter: Q3 2015
Previous quarter: Q1 2015
ALNYLAM PHARMACEUTICALS, INC. SEC filings
ALNYLAM PHARMACEUTICALS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 02043Q107
Recent filing periods:
Top shareholders of ALNY - ALNYLAM PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
9.4%
|
12,564,021
|
$1,311,935,000 | — | 31 Mar 2015 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
7.8%
|
10,440,814
|
$1,090,230,000 | — | 31 Mar 2015 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.3%
|
4,327,986
|
$451,929,000 | — | 31 Mar 2015 | |
| Capital World Investors |
13F
|
Company |
1.6%
|
2,138,700
|
$223,323,000 | — | 31 Mar 2015 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
1.3%
|
1,774,292
|
$185,273,000 | — | 31 Mar 2015 | |
| BlackRock Institutional Trust Company, N.A. |
13F
|
Company |
1.3%
|
1,759,334
|
$183,710,000 | — | 31 Mar 2015 | |
| GILDER GAGNON HOWE & CO LLC |
13F
|
Company |
1.3%
|
1,748,367
|
$182,564,000 | — | 31 Mar 2015 | |
| BlackRock Fund Advisors |
13F
|
Company |
1.3%
|
1,692,612
|
$176,743,000 | — | 31 Mar 2015 | |
| MORGAN STANLEY |
13F
|
Company |
1.1%
|
1,399,524
|
$146,139,000 | — | 31 Mar 2015 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.95%
|
1,261,604
|
$131,737,000 | — | 31 Mar 2015 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.94%
|
1,254,525
|
$130,998,000 | — | 31 Mar 2015 | |
| STATE STREET CORP |
13F
|
Company |
0.87%
|
1,160,599
|
$121,190,000 | — | 31 Mar 2015 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.85%
|
1,126,045
|
$117,581,000 | — | 31 Mar 2015 | |
| Artisan Partners Limited Partnership |
13F
|
Company |
0.81%
|
1,084,560
|
$113,250,000 | — | 31 Mar 2015 | |
| BAILLIE GIFFORD & CO |
13F
|
Company |
0.77%
|
1,023,430
|
$106,866,000 | — | 31 Mar 2015 | |
| Blue Ridge Capital, L.L.C. |
13F
|
Company |
0.72%
|
960,000
|
$100,243,000 | — | 31 Mar 2015 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
0.71%
|
945,847
|
$98,765,000 | — | 31 Mar 2015 | |
| Alpha Wave Global, LP |
13F
|
Company |
0.65%
|
871,713
|
$91,024,000 | — | 31 Mar 2015 | |
| Slate Path Capital LP |
13F
|
Company |
0.64%
|
855,000
|
$89,279,000 | — | 31 Mar 2015 | |
| BB BIOTECH AG |
13F
|
Company |
0.63%
|
835,499
|
$87,243,000 | — | 31 Mar 2015 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.58%
|
778,025
|
$81,242,000 | — | 31 Mar 2015 | |
| 12 West Capital Management LP |
13F
|
Company |
0.49%
|
651,000
|
$67,977,000 | — | 31 Mar 2015 | |
| BRIDGER MANAGEMENT, LLC |
13F
|
Company |
0.47%
|
626,758
|
$65,446,000 | — | 31 Mar 2015 | |
| NORGES BANK |
13F
|
Company |
0.45%
|
595,294
|
$62,160,000 | — | 31 Mar 2015 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.45%
|
595,105
|
$62,141,000 | — | 31 Mar 2015 | |
| Invesco Ltd. |
13F
|
Company |
0.4%
|
529,747
|
$55,316,000 | — | 31 Mar 2015 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.4%
|
526,329
|
$54,959,000 | — | 31 Mar 2015 | |
| AMUNDI ASSET MANAGEMENT US, INC. |
13F
|
Company |
0.36%
|
484,824
|
$50,625,000 | — | 31 Mar 2015 | |
| Artal Group S.A. |
13F
|
Company |
0.35%
|
470,000
|
$49,077,000 | — | 31 Mar 2015 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.31%
|
410,976
|
$42,914,000 | — | 31 Mar 2015 | |
| COLUMBIA WANGER ASSET MANAGEMENT LLC |
13F
|
Company |
0.3%
|
402,500
|
$42,029,000 | — | 31 Mar 2015 | |
| Global Thematic Partners, LLC |
13F
|
Company |
0.29%
|
385,334
|
$40,234,000 | — | 31 Mar 2015 | |
| RTW INVESTMENTS, LP |
13F
|
Company |
0.27%
|
355,395
|
$37,110,000 | — | 31 Mar 2015 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
0.26%
|
343,318
|
$35,849,000 | — | 31 Mar 2015 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.24%
|
321,840
|
$33,606,000 | — | 31 Mar 2015 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.22%
|
298,785
|
$31,198,000 | — | 31 Mar 2015 | |
| COLUMBUS CIRCLE INVESTORS |
13F
|
Company |
0.22%
|
289,560
|
$30,236,000 | — | 31 Mar 2015 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.21%
|
281,619
|
$29,399,000 | — | 31 Mar 2015 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.2%
|
271,954
|
$28,398,000 | — | 31 Mar 2015 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.2%
|
267,612
|
$27,944,000 | — | 31 Mar 2015 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.19%
|
256,335
|
$26,767,000 | — | 31 Mar 2015 | |
| Catalyst Capital Advisors LLC |
13F
|
Company |
0.15%
|
200,250
|
$20,911,000 | — | 31 Mar 2015 | |
| TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY |
13F
|
Company |
0.14%
|
188,535
|
$19,686,000 | — | 31 Mar 2015 | |
| VAN ECK ASSOCIATES CORP |
13F
|
Company |
0.14%
|
187,428
|
$19,571,000 | — | 31 Mar 2015 | |
| LOS ANGELES CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.12%
|
163,057
|
$17,026,000 | — | 31 Mar 2015 | |
| TIGER MANAGEMENT L.L.C. |
13F
|
Company |
0.12%
|
161,600
|
$16,874,000 | — | 31 Mar 2015 | |
| FIC CAPITAL INC |
13F
|
Company |
0.12%
|
160,032
|
$16,711,000 | — | 31 Mar 2015 | |
| BLACKROCK ADVISORS LLC |
13F
|
Company |
0.11%
|
145,910
|
$15,236,000 | — | 31 Mar 2015 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.1%
|
138,958
|
$14,510,000 | — | 31 Mar 2015 | |
| GUGGENHEIM CAPITAL LLC |
13F
|
Company |
0.1%
|
136,340
|
$14,237,000 | — | 31 Mar 2015 |
Institutional Holders of ALNYLAM PHARMACEUTICALS, INC. - Common Stock (ALNY) as of Q2 2015
As of 30 Jun 2015,
ALNYLAM PHARMACEUTICALS, INC. - Common Stock (ALNY) was held by
274 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
65,565,499 shares.
The largest 10 holders included
FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, Capital World Investors, UBS GLOBAL ASSET MANAGEMENT AMERICAS INC, BlackRock Fund Advisors, BlackRock Institutional Trust Company, N.A., PRICE T ROWE ASSOCIATES INC /MD/, FIRST TRUST ADVISORS LP, and GILDER GAGNON HOWE & CO LLC.
This page lists
274
institutional shareholders reporting positions in this security
for the Q2 2015 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2015 vs Q1 2015 Across Filers
Q1 2015 holders
236
Q2 2015 holders
274
Holder diff
38
| Investor | Q1 2015 Shares | Q2 2015 Shares | Share Diff | Share Chg % | Q1 2015 Value $ | Q2 2015 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.